The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Kazunori Kageyama

Department of Endocrinology and Metabolism

Hirosaki University Graduate School of Medicine

5 Zaifu-cho

Hirosaki

Japan

[email]@hkg.odn.ne.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Japan. 2001 - 2012
  • The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, USA. 2003

References

  1. Action of glucagon-like peptide 1 and glucose levels on corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells. Kageyama, K., Yamagata, S., Akimoto, K., Sugiyama, A., Murasawa, S., Suda, T. Mol. Cell. Endocrinol. (2012) [Pubmed]
  2. Corticotrophin-releasing factor gene transcription is directly activated after deprivation of glucocorticoids in hypothalamic cells. Kageyama, K., Akimoto, K., Suda, T. J. Neuroendocrinol. (2010) [Pubmed]
  3. Differential regulation and roles of urocortins in human adrenal H295R cells. Kageyama, K., Hanada, K., Suda, T. Regul. Pept. (2010) [Pubmed]
  4. Role and action in the pituitary corticotroph of corticotropin-releasing factor (CRF) in the hypothalamus. Kageyama, K., Suda, T. Peptides (2009) [Pubmed]
  5. Regulation and role of suppressor of cytokine signaling-3 in hypothalamic 4B cells. Kageyama, K., Hanada, K., Iwasaki, Y., Suda, T. J. Endocrinol. (2009) [Pubmed]
  6. Deficiency of growth hormone in an adult man case of idiopathic adrenocorticotropin deficiency. Kageyama, K., Tsushima, Y., Tomotsune, K., Yanagimachi, M., Sakihara, S., Suda, T. Intern. Med. (2009) [Pubmed]
  7. Differential regulation of urocortins1-3 mRNA in human umbilical vein endothelial cells. Kageyama, K., Hanada, K., Suda, T. Regul. Pept. (2009) [Pubmed]
  8. Regulation and role of p21-activated kinase 3 by corticotropin-releasing factor in mouse pituitary. Kageyama, K., Sakihara, S., Suda, T. Regul. Pept. (2009) [Pubmed]
  9. Growth hormone-releasing peptide-2 stimulates secretion and synthesis of adrenocorticotropic hormone in mouse pituitary. Kageyama, K., Kushibiki, M., Hanada, K., Sakihara, S., Yasujima, M., Suda, T. Regul. Pept. (2009) [Pubmed]
  10. Involvement of regulatory elements on corticotropin-releasing factor gene promoter in hypothalamic 4B cells. Kageyama, K., Hanada, K., Takayasu, S., Iwasaki, Y., Sakihara, S., Nigawara, T., Suda, T. J. Endocrinol. Invest. (2008) [Pubmed]
  11. A progressive case of lymphocytic hypophysitis accompanied by paresis of the left abducens nerve. Kageyama, K., Naraoka, M., Sakihara, S., Ikeda, H., Sano, T., Suda, T. Intern. Med. (2008) [Pubmed]
  12. A case of multiple endocrine neoplasia type II accompanied by thyroid medullary carcinoma and pheochromocytomas expressing corticotropin-releasing factor and urocortins. Kageyama, K., Sakihara, S., Yamashita, M., Takahashi, K., Kawashima, S., Tanabe, J., Tsutaya, S., Yasujima, M., Suda, T. Am. J. Med. Sci. (2008) [Pubmed]
  13. Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells. Kageyama, K., Hanada, K., Nigawara, T., Furukawa, K., Terui, K., Ogura, E., Motomura, S., Suda, T. Peptides (2007) [Pubmed]
  14. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. Kageyama, K., Hanada, K., Iwasaki, Y., Sakihara, S., Nigawara, T., Kasckow, J., Suda, T. J. Endocrinol. (2007) [Pubmed]
  15. A case of thyrotropin-producing pituitary adenoma, accompanied by an increase in anti-thyrotropin receptor antibody after tumor resection. Kageyama, K., Ikeda, H., Sakihara, S., Nigawara, T., Terui, K., Tsutaya, S., Matsuda, E., Shoji, M., Yasujima, M., Suda, T. J. Endocrinol. Invest. (2007) [Pubmed]
  16. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells. Kageyama, K., Hanada, K., Moriyama, T., Imaizumi, T., Satoh, K., Suda, T. Mol. Cell. Endocrinol. (2007) [Pubmed]
  17. G protein-coupled receptor kinase 2 involvement in desensitization of corticotropin-releasing factor (CRF) receptor type 1 by CRF in murine corticotrophs. Kageyama, K., Hanada, K., Moriyama, T., Nigawara, T., Sakihara, S., Suda, T. Endocrinology (2006) [Pubmed]
  18. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells. Kageyama, K., Kimura, R., Suga, S., Ogawa, Y., Suda, T., Wakui, M. Peptides (2006) [Pubmed]
  19. Urocortin induces interleukin-6 gene expression via cyclooxygenase-2 activity in aortic smooth muscle cells. Kageyama, K., Hanada, K., Nigawara, T., Moriyama, T., Terui, K., Sakihara, S., Suda, T. Endocrinology (2006) [Pubmed]
  20. Gene analysis of the calcium channel 1 subunit and clinical studies for two patients with hypokalemic periodic paralysis. Kageyama, K., Terui, K., Tsutaya, S., Matsuda, E., Shoji, M., Sakihara, S., Nigawara, T., Takayasu, S., Moriyama, T., Yasujima, M., Suda, T. J. Endocrinol. Invest. (2006) [Pubmed]
  21. Regulation of corticotropin-releasing factor receptor type 2beta mRNA by mitogen-activated protein kinases in aortic smooth muscle cells. Kageyama, K., Hanada, K., Suda, T. Regul. Pept. (2005) [Pubmed]
  22. Usefulness of the thyrotropin-releasing hormone test in pre-clinical acromegaly. Kageyama, K., Moriyama, T., Sakihara, S., Takayasu, S., Nigawara, T., Suda, T. Tohoku J. Exp. Med. (2005) [Pubmed]
  23. Diagnosis of a case of Gitelman's syndrome based on renal clearance studies and gene analysis of a novel mutation of the thiazide-sensitive Na-Cl cotransporter. Kageyama, K., Terui, K., Shoji, M., Tsutaya, S., Matsuda, E., Sakihara, S., Nigawara, T., Moriyama, T., Yasujima, M., Suda, T. J. Endocrinol. Invest. (2005) [Pubmed]
  24. Regulation of corticotropin-releasing factor receptor type 2beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells. Kageyama, K., Gaudriault, G.E., Suda, T., Vale, W.W. Cell. Signal. (2003) [Pubmed]
  25. Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5'-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells. Kageyama, K., Suda, T. Endocrinology (2003) [Pubmed]
  26. Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta. Kageyama, K., Furukawa, K., Miki, I., Terui, K., Motomura, S., Suda, T. J. Cardiovasc. Pharmacol. (2003) [Pubmed]
  27. A multihormonal pituitary adenoma with growth hormone and adrenocorticotropic hormone production, causing acromegaly and Cushing disease. Kageyama, K., Nigawara, T., Kamata, Y., Terui, K., Anzai, J., Sakihara, S., Suda, T. Am. J. Med. Sci. (2002) [Pubmed]
  28. Regulation of corticotropin-releasing factor receptor type 2beta messenger ribonucleic acid by interleukin-1beta in rat vascular smooth muscle cells. Kageyama, K., Suda, T. Neuroimmunomodulation (2001) [Pubmed]
 
WikiGenes - Universities